Literature DB >> 17714568

Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score.

A P Oranje1, E J Glazenburg, A Wolkerstorfer, F B de Waard-van der Spek.   

Abstract

It is important to determine the severity of atopic dermatitis (AD) for evaluation of disease improvement after and during therapy. Scoring of the severity of AD is demanded in clinical trials. The European Task Force on Atopic Dermatitis (ETFAD) has developed the SCORAD (SCORing AD) index to create a consensus on assessment methods for AD, so that study results of different trials can be compared. However, modification of the SCORAD index has led on several occasions to wrong and incorrect use of the system. To measure the extent of AD, the rule of nines is applied on a front/back drawing of the patient's inflammatory lesions. The extent can be graded 0-100. The intensity part of the SCORAD index consists of six items: erythema, oedema/papulation, excoriations, lichenification, oozing/crusts and dryness. Each item can be graded on a scale 0-3. The subjective items include daily pruritus and sleeplessness. Both subjective items can be graded on a 10-cm visual analogue scale. The maximum subjective score is 20. All items should be filled out in the SCORAD evaluation form. The SCORAD index formula is: A/5 + 7B/2 + C. In this formula A is defined as the extent (0-100), B is defined as the intensity (0-18) and C is defined as the subjective symptoms (0-20). The maximum SCORAD score is 103. Based on training sessions by the ETFAD, the SCORAD index was modified by excluding the subjective symptoms (objective SCORAD). The objective SCORAD consists of just the extent and intensity items, the formula being A/5 + 7B/2. The maximum objective SCORAD score is 83 (plus an additional 10 bonus points). Bonus points are given for severe disfiguring eczema (on face and hands). The three-item severity (TIS) score involves the scoring of erythema (redness), oedema and excoriations (scratches) in one representative lesion, marked as R-O-S. The TIS score corresponds well with the more detailed objective SCORAD and can be used as a prescreening system or as a quick system in studies and is excellent for epidemiological studies.

Entities:  

Mesh:

Year:  2007        PMID: 17714568     DOI: 10.1111/j.1365-2133.2007.08112.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  87 in total

1.  Association of staphylococcal superantigen-specific immunoglobulin e with mild and moderate atopic dermatitis.

Authors:  Peck Y Ong; Mona Patel; Ronald M Ferdman; Theresa Dunaway; Joseph A Church
Journal:  J Pediatr       Date:  2008-07-14       Impact factor: 4.406

2.  Relationship Between Serum Interleukin-17F Level and Severity of Atopic Dermatitis in Children.

Authors:  Young A Park; Yoon Hee Kim; In Suk Sol; Seo Hee Yoon; Jung Yeon Hong; Mi Na Kim; Kyung Eun Lee; Kyung Won Kim; Kyu-Earn Kim; Myung Hyun Sohn
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-06-01       Impact factor: 1.349

3.  Recombinant human interferon gamma (Gamma Immunex) in treatment of atopic dermatitis.

Authors:  Yunes Panahi; Seyyed Masoud Davoudi; Nima Madanchi; Ehsan Abolhasani
Journal:  Clin Exp Med       Date:  2011-11-19       Impact factor: 3.984

4.  The Efficacy and Safety of Long-term Oral Cyclosporine Treatment for Patients with Atopic Dermatitis.

Authors:  Sik Haw; Min-Kyung Shin; Choong-Rim Haw
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

5.  Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.

Authors:  Eric L Simpson; Emma Guttman-Yassky; David J Margolis; Steven R Feldman; Abrar Qureshi; Tissa Hata; Vera Mastey; Wenhui Wei; Laurent Eckert; Jingdong Chao; Renée J G Arnold; Tiffany Yu; Francis Vekeman; Mayte Suárez-Fariñas; Abhijit Gadkari
Journal:  JAMA Dermatol       Date:  2018-08-01       Impact factor: 10.282

6.  Towards better triage of infants suspected of cow's milk allergy: development of a preliminary multivariable diagnostic index.

Authors:  Anders van Thuijl; Anne-Fleur Schoemaker; Stef Menting; Jennifer van Dulmen; Janne Boeting; Wim van Aalderen; Gerben ter Riet; Aline Sprikkelman
Journal:  Eur J Pediatr       Date:  2012-12-08       Impact factor: 3.183

7.  Determining the severity of atopic dermatitis in children presenting in general practice: an easy and fast method.

Authors:  Marjolein G Willemsen; Rosalinda W C van Valburg; Pauline C Dirven-Meijer; Arnold P Oranje; Johannes C van der Wouden; Heleen Moed
Journal:  Dermatol Res Pract       Date:  2009-11-18

Review 8.  Systemic therapy of atopic dermatitis in children.

Authors:  Giampaolo Ricci; Arianna Dondi; Annalisa Patrizi; Massimo Masi
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children.

Authors:  S J Brown; C L Relton; H Liao; Y Zhao; A Sandilands; W H I McLean; H J Cordell; N J Reynolds
Journal:  Br J Dermatol       Date:  2009-06-11       Impact factor: 9.302

10.  The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis.

Authors:  Joanna Narbutt; Aleksandra Lesiak; Anna Sysa-Jedrzeiowska; Marcin Zakrzewski; Jarosław Bogaczewicz; Iwona Stelmach; Piotr Kuna
Journal:  Mediators Inflamm       Date:  2009-07-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.